{"id":1832,"date":"2023-11-14T11:56:23","date_gmt":"2023-11-14T10:56:23","guid":{"rendered":"https:\/\/galpharma.tn\/?post_type=medicament&#038;p=1832"},"modified":"2023-11-18T09:25:52","modified_gmt":"2023-11-18T08:25:52","slug":"copred-odt-3","status":"publish","type":"medicament","link":"https:\/\/galpharma.tn\/en\/medicaments\/copred-odt-3\/","title":{"rendered":"COPRED ODT"},"content":{"rendered":"<p>Conditions or diseases: &#8211; Collagenosis, connective tissue disease: Progressive outbreaks of systemic diseases, in particular: systemic lupus erythematosus, vasculitis, polymyositis, visceral sarcoidosis. &#8211; Dermatological: Severe autoimmune bullous dermatoses, in particular pemphigus and bullous pemphigoid. Severe forms of angiomas in infants. Certain forms of lichen planus. Some acute urticaria. Severe forms of neutrophilic dermatoses. &#8211; Digestive: Progressive outbreaks of ulcerative colitis and Crohn&#8217;s disease. Chronic active autoimmune hepatitis (with or without cirrhosis). Severe acute alcoholic hepatitis, histologically proven. &#8211; Endocrine: Severe subacute de Quervain thyroiditis. Certain hypercalcemias. &#8211; Hematological: Severe immunological thrombocytopenic purpuras. Autoimmune hemolytic anemias. In combination with various chemotherapies in the treatment of lymphoid malignancies. Chronic, acquired or congenital red cell aplasia. &#8211; Infectious: Tuberculous pericarditis and serious forms of life-threatening tuberculosis. Pneumocystis carinii pneumonia with severe hypoxia. &#8211; Neoplastics: Antiemetic treatment during antineoplastic chemotherapy. Edematous and inflammatory flare-up associated with antineoplastic treatments (radio and chemotherapy). &#8211; Nephrological: Nephrotic syndrome with minimal glomerular lesions. Nephrotic syndrome of primary segmental and focal hyalinoses. Stages III and IV of lupus nephropathy. Intrarenal granulomatous sarcoidosis.Vasculitis with renal damage. Primary extracapillary glomerulonephritis. &#8211; Neurological: Myasthenia. Cerebral edema caused by tumor. Chronic, idiopathic, inflammatory polyradiculoneuritis. Infantile spasm (West syndrome), Lennox-Gastaut syndrome. Multiple sclerosis in flare-up, following intravenous corticosteroid therapy. &#8211; Ophthalmological: Severe anterior and posterior uveitis. Edematous exophthalmos. Certain optic neuropathies, following intravenous corticosteroid therapy (in this indication, the oral route as first intention is not recommended). &#8211; ENT: Certain serous ear infections. Nasosinusal polyposis. Certain acute or chronic sinusitis. Seasonal allergic rhinitis in short course. Acute stridular laryngitis (subglottic laryngitis) in children. Respiratory: Persistent asthma preferably in a short course in the event of failure of high-dose inhalation treatment. Exacerbations of asthma, especially severe acute asthma. Chronic obstructive pulmonary disease in evaluation of the reversibility of the obstructive syndrome. Progressive sarcoidosis. Diffuse interstitial pulmonary fibrosis. &#8211; Rheumatological: Rheumatoid arthritis and certain polyarthritis. Rhizomelic pseudopolyarthritis and Horton&#8217;s disease. Acute articular rhumatism. Severe and intractable cervicobrachial neuralgia. &#8211; Organ and allogeneic hematopoietic stem cell transplantation: Prophylaxis or treatment of graft rejection. Prophylaxis or treatment of graft-versus-host disease.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Conditions or diseases: &#8211; Collagenosis, connective tissue disease: Progressive outbreaks of systemic diseases, in particular: systemic lupus erythematosus, vasculitis, polymyositis, visceral sarcoidosis. &#8211; Dermatological: Severe autoimmune bullous dermatoses, in particular pemphigus and bullous pemphigoid. Severe forms of angiomas in infants. Certain forms of lichen planus. Some acute urticaria. Severe forms of neutrophilic dermatoses. &#8211; Digestive: [&hellip;]<\/p>\n","protected":false},"featured_media":0,"parent":0,"template":"","class_list":["post-1832","medicament","type-medicament","status-publish","hentry","dci-prednisolone-2","class_therapeutique-anti-inflamatories","galenique-orodispersible-tablet"],"_links":{"self":[{"href":"https:\/\/galpharma.tn\/en\/wp-json\/wp\/v2\/medicament\/1832","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/galpharma.tn\/en\/wp-json\/wp\/v2\/medicament"}],"about":[{"href":"https:\/\/galpharma.tn\/en\/wp-json\/wp\/v2\/types\/medicament"}],"wp:attachment":[{"href":"https:\/\/galpharma.tn\/en\/wp-json\/wp\/v2\/media?parent=1832"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}